{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:41:24Z","timestamp":1790534484592,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T00:00:00Z","timestamp":1405296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T00:00:00Z","timestamp":1405296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,5,14]]},"DOI":"10.1038\/onc.2014.207","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T07:05:19Z","timestamp":1405494319000},"page":"2672-2680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs"],"prefix":"10.1038","volume":"34","author":[{"given":"M","family":"Saqcena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hosny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Alhamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,14]]},"reference":[{"key":"BFonc2014207_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFonc2014207_CR2","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1007\/s00018-008-8224-x","volume":"65","author":"SJ Yeung","year":"2008","unstructured":"Yeung SJ, Pan J, Lee MH . Roles of p53, MYC and HIF-1 in regulating glycolysis\u2014the seventh hallmark of cancer. Cell Mol Life Sci 2008; 65: 3981\u20133999.","journal-title":"Cell Mol Life Sci"},{"key":"BFonc2014207_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB . The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7: 11\u201320.","journal-title":"Cell Metab"},{"key":"BFonc2014207_CR4","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 2007; 104: 19345\u201319350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014207_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E . The metabolism of tumors in the body. J Gen Physiol 1927; 8: 519\u2013530.","journal-title":"J Gen Physiol"},{"key":"BFonc2014207_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB . Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029\u20131033.","journal-title":"Science"},{"key":"BFonc2014207_CR7","doi-asserted-by":"publisher","first-page":"18782","DOI":"10.1073\/pnas.0810199105","volume":"105","author":"DR Wise","year":"2008","unstructured":"Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 2008; 105: 18782\u201318787.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014207_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T et al. c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458: 762\u2013765.","journal-title":"Nature"},{"key":"BFonc2014207_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00109-011-0731-9","volume":"89","author":"NP Shanware","year":"2011","unstructured":"Shanware NP, Mullen AR, DeBerardinis RJ, Abraham RT . Glutamine: pleiotropic roles in tumor growth and stress resistance. J Mol Med 2011; 89: 229\u2013236.","journal-title":"J Mol Med"},{"key":"BFonc2014207_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/onc.2009.358","volume":"29","author":"RJ DeBerardinis","year":"2010","unstructured":"DeBerardinis RJ, Cheng T . Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010; 29: 313\u2013324.","journal-title":"Oncogene"},{"key":"BFonc2014207_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1083\/jcb.200703099","volume":"178","author":"M Yuneva","year":"2007","unstructured":"Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y . Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 2007; 178: 93\u2013105.","journal-title":"J Cell Biol"},{"key":"BFonc2014207_CR12","doi-asserted-by":"publisher","first-page":"e4715","DOI":"10.1371\/journal.pone.0004715","volume":"4","author":"D Gaglio","year":"2009","unstructured":"Gaglio D, Soldati C, Vanoni M, Alberghina L, Chiaradonna F . Glutamine deprivation induces abortive S-phase rescued by deoxyribonucleotides in K-Ras transformed fibroblasts. PLoS ONE 2009; 4: e4715.","journal-title":"PLoS ONE"},{"key":"BFonc2014207_CR13","doi-asserted-by":"publisher","first-page":"e74157","DOI":"10.1371\/journal.pone.0074157","volume":"8","author":"M Saqcena","year":"2013","unstructured":"Saqcena M, Menon D, Patel D, Mukhopadhyay S, Chow V, Foster DA . Amino acids and mTOR mediate distinct metabolic checkpoints in mammalian G1 cell cycle. PLoS ONE 2013; 8: e74157.","journal-title":"PLoS ONE"},{"key":"BFonc2014207_CR14","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1073\/pnas.71.4.1286","volume":"71","author":"AB Pardee","year":"1974","unstructured":"Pardee AB . A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 1974; 71: 1286\u20131290.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014207_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature13079","volume":"508","author":"P Liu","year":"2014","unstructured":"Liu P, Begley M, Michowski W, Inuzuka H, Ginzberg M, Gao D et al. Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 2014; 508: 541\u2013545.","journal-title":"Nature"},{"key":"BFonc2014207_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/22780","volume":"400","author":"WC Hahn","year":"1999","unstructured":"Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA . Creation of human tumour cells with defined genetic elements. Nature 1999; 400: 464\u2013468.","journal-title":"Nature"},{"key":"BFonc2014207_CR17","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1128\/MCB.22.7.2111-2123.2002","volume":"22","author":"WC Hahn","year":"2002","unstructured":"Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22: 2111\u20132123.","journal-title":"Mol Cell Biol"},{"key":"BFonc2014207_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1177\/1947601910392989","volume":"1","author":"DA Foster","year":"2010","unstructured":"Foster DA, Yellen P, Xu L, Saqcena M . Regulation of G1 cell cycle progression: distinguishing the restriction point from a nutrient-sensing cell growth checkpoint(s). Genes Cancer 2010; 1: 1124\u20131131.","journal-title":"Genes Cancer"},{"key":"BFonc2014207_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","volume":"36","author":"MC Mendoza","year":"2011","unstructured":"Mendoza MC, Er EE, Blenis J . The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci 2011; 36: 320\u2013328.","journal-title":"Trends Biochem Sci"},{"key":"BFonc2014207_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0960-9822(00)00177-9","volume":"4","author":"T Kodaki","year":"1994","unstructured":"Kodaki T, Woscholski R, Hallberg B, Rodriguez-Viciana P, Downward J, Parker PJ . The activation of phosphatidylinositol 3-kinase by Ras. Curr Biol 1994; 4: 798\u2013806.","journal-title":"Curr Biol"},{"key":"BFonc2014207_CR21","doi-asserted-by":"publisher","first-page":"13489","DOI":"10.1073\/pnas.0405659101","volume":"101","author":"PP Roux","year":"2004","unstructured":"Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J . Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA 2004; 101: 13489\u201313494.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014207_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","volume":"279","author":"AG Bodnar","year":"1998","unstructured":"Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349\u2013352.","journal-title":"Science"},{"key":"BFonc2014207_CR23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593\u2013602.","journal-title":"Cell"},{"key":"BFonc2014207_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/318472a0","volume":"318","author":"GP Dotto","year":"1985","unstructured":"Dotto GP, Parada LF, Weinberg RA . Specific growth response of ras-transformed embryo fibroblasts to tumour promoters. Nature 1985; 318: 472\u2013475.","journal-title":"Nature"},{"key":"BFonc2014207_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","volume":"27","author":"CM Walko","year":"2005","unstructured":"Walko CM, Lindley C . Capecitabine: a review. Clin Ther 2005; 27: 23\u201344.","journal-title":"Clin Ther"},{"key":"BFonc2014207_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nm0196-72","volume":"2","author":"AF Wahl","year":"1996","unstructured":"Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW et al. Loss of normal p53 function confers sensitization to Taxol by increasing G2\/M arrest and apoptosis. Nat Med 1996; 2: 72\u201379.","journal-title":"Nat Med"},{"key":"BFonc2014207_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.gde.2008.02.003","volume":"18","author":"RJ Deberardinis","year":"2008","unstructured":"Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB . Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 2008; 18: 54\u201361.","journal-title":"Curr Opin Genet Dev"},{"key":"BFonc2014207_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 2013; 496: 101\u2013105.","journal-title":"Nature"},{"key":"BFonc2014207_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB . Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010; 35: 427\u2013433.","journal-title":"Trends Biochem Sci"},{"key":"BFonc2014207_CR30","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/bcr2154","volume":"10","author":"JM Thornburg","year":"2008","unstructured":"Thornburg JM, Nelson KK, Clem BF, Lane AN, Arumugam S, Simmons A et al. Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res 2008; 10: R84.","journal-title":"Breast Cancer Res"},{"key":"BFonc2014207_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB . Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012; 21: 297\u2013308.","journal-title":"Cancer Cell"},{"key":"BFonc2014207_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/2159-8274.CD-10-0022","volume":"1","author":"XS Wang","year":"2011","unstructured":"Wang XS, Shankar S, Dhanasekaran SM, Ateeq B, Sasaki AT, Jing X et al. Characterization of KRAS rearrangements in metastatic prostate cancer. Cancer Discov 2011; 1: 35\u201343.","journal-title":"Cancer Discov"},{"key":"BFonc2014207_CR33","first-page":"4682","volume":"49","author":"JL Bos","year":"1989","unstructured":"Bos JL . ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682\u20134689.","journal-title":"Cancer Res"},{"key":"BFonc2014207_CR34","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1053\/j.gastro.2005.04.001","volume":"128","author":"G Schneider","year":"2005","unstructured":"Schneider G, Siveke JT, Eckel F, Schmid RM . Pancreatic cancer: basic and clinical aspects. Gastroenterology 2005; 128: 1606\u20131625.","journal-title":"Gastroenterology"},{"key":"BFonc2014207_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature12248","volume":"497","author":"NM Baker","year":"2013","unstructured":"Baker NM, Der CJ . Cancer: drug for an 'undruggable' protein. Nature 2013; 497: 577\u2013578.","journal-title":"Nature"},{"key":"BFonc2014207_CR36","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1073\/pnas.1307237110","volume":"110","author":"JJ Kamphorst","year":"2013","unstructured":"Kamphorst JJ, Cross JR, Fan J, de Stanchina E, Mathew R, White EP et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci USA 2013; 110: 8882\u20138887.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014207_CR37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1158\/1535-7163.MCT-13-0762","volume":"13","author":"D Salloum","year":"2014","unstructured":"Salloum D, Mukhopadhyay S, Tung K, Polonetskaya A, Foster DA . Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin. Mol Cancer Ther 2014; 13: 733\u2013741.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2014207_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature12138","volume":"497","author":"C Commisso","year":"2013","unstructured":"Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ, Hackett S et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 2013; 497: 633\u2013637.","journal-title":"Nature"},{"key":"BFonc2014207_CR39","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkq929","volume":"39","author":"SA Forbes","year":"2011","unstructured":"Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 2011; 39: D945\u2013D950.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2014207_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603\u2013607.","journal-title":"Nature"},{"key":"BFonc2014207_CR41","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/sj.onc.1208099","volume":"24","author":"Y Chen","year":"2005","unstructured":"Chen Y, Rodrik V, Foster DA . Alternative phospholipase D\/mTOR survival signal in human breast cancer cells. Oncogene 2005; 24: 672\u2013679.","journal-title":"Oncogene"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2014207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014207","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:23:54Z","timestamp":1647894234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,14]]},"references-count":41,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2015,5,14]]}},"alternative-id":["BFonc2014207"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.207","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,14]]},"assertion":[{"value":"20 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}